Loading…

Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy

Proliferative enteropathy is caused by the microaerophilic obligate intracellular bacterium ileal symbiont (IS) intracellularis. Treatment of this disease is problematic because of the lack of in vivo or in vitro data on the activities of antimicrobial agents. A new procedure for determining the sus...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Clinical Microbiology 1995-05, Vol.33 (5), p.1314-1317
Main Authors: McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.), Mackie, R.A, Lawson, G.H.K
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c570t-8c0b10cb264eb10f3cbb42302dd606adfe684dbc5bb4144dfa526236aa0de4cf3
cites
container_end_page 1317
container_issue 5
container_start_page 1314
container_title Journal of Clinical Microbiology
container_volume 33
creator McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.)
Mackie, R.A
Lawson, G.H.K
description Proliferative enteropathy is caused by the microaerophilic obligate intracellular bacterium ileal symbiont (IS) intracellularis. Treatment of this disease is problematic because of the lack of in vivo or in vitro data on the activities of antimicrobial agents. A new procedure for determining the susceptibility of IS intracellularis was developed by using a tissue culture system which promotes the in vitro multiplication of this organism. Nineteen antimicrobial agents were evaluated in triplicate cultures for their intracellular and extracellular activities against up to three IS intracellularis strains isolated from pigs with proliferative enteropathy. The MIC was defined as the lowest concentration which prevented multiplication of 99% of the IS intracellularis isolates. Penicillin, erythromycin, difioxacin, virginiamycin, and chlortetracycline were the most active compounds tested, all with MICs of less than or equal to 1 microgram/ml. Tiamulin and tilmicosin were the next most active compounds, with MICs of less than or equal to 4 microgram/ml. The MICs of aminoglycosides were generally 32 microgram/ml. Both lincomycin and tylosin were relatively inactive against the IS intracellularis strains tested, with MICs of 32 and 64 microgram/ml, respectively. These results indicate that some compounds capable of intracytoplasmic accumulation and blocking bacterial protein synthesis were active against IS intracellularis strains isolated from pigs with proliferative enteropathy. The in vitro cultivation system shows promise as a method for studying the interaction between IS intracellularis and antimicrobial agents and for screening new antibiotics for use in therapy
doi_str_mv 10.1128/jcm.33.5.1314-1317.1995
format article
fullrecord <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_highwire_asm_jcm_33_5_1314</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16761876</sourcerecordid><originalsourceid>FETCH-LOGICAL-c570t-8c0b10cb264eb10f3cbb42302dd606adfe684dbc5bb4144dfa526236aa0de4cf3</originalsourceid><addsrcrecordid>eNqFkV2L1TAQhoso63H1DwhiBfGuNR9N0l54sSx-wYIXuuBdSNPkdJa0qUm6y_n3ppzDwb3yJgkzzzuZmbco3mJUY0zaj3d6qimtWY0pbqp8iBp3HXtS7DDq2opz9PtpsUOoYxXGVDwvXsR4hxBuGsYuigvBMRON2BXL1ZxgAh18D8qVcY3aLAl6cJAOpbclOLPFD1MPfk4lzCkobZxbnQoQS4jeqWSG0gY_lQvsY_kAaSyX4B1YE1SCe1OaOZngF5XGw8vimVUumlen-7K4_fL51_W36ubH1-_XVzeVZgKlqtWox0j3hDcmPyzVfd8QisgwcMTVYA1vm6HXLIfzUINVjHBCuVJoMI229LL4dKy7rP1kBm22xp1cAkwqHKRXIB9nZhjl3t9LQlrMSNZ_OOmD_7OamOQEcRtczcavUQrRICJa_l8Q87zsVmygOIJ52TEGY8_NYCQ3U2U2VVIqmdxM3Q4hN1Oz8s2_s5x1Jxdz_v0pr6JWzgY1a4hnjDIkGMEZe3fERtiPDxCMVHF6_GlmXh8Zq7xU-2yxvP3Z8byUXOAvMV_EHg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16761876</pqid></control><display><type>article</type><title>Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy</title><source>American Society for Microbiology Journals</source><source>PubMed Central</source><creator>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.) ; Mackie, R.A ; Lawson, G.H.K</creator><creatorcontrib>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.) ; Mackie, R.A ; Lawson, G.H.K</creatorcontrib><description>Proliferative enteropathy is caused by the microaerophilic obligate intracellular bacterium ileal symbiont (IS) intracellularis. Treatment of this disease is problematic because of the lack of in vivo or in vitro data on the activities of antimicrobial agents. A new procedure for determining the susceptibility of IS intracellularis was developed by using a tissue culture system which promotes the in vitro multiplication of this organism. Nineteen antimicrobial agents were evaluated in triplicate cultures for their intracellular and extracellular activities against up to three IS intracellularis strains isolated from pigs with proliferative enteropathy. The MIC was defined as the lowest concentration which prevented multiplication of 99% of the IS intracellularis isolates. Penicillin, erythromycin, difioxacin, virginiamycin, and chlortetracycline were the most active compounds tested, all with MICs of less than or equal to 1 microgram/ml. Tiamulin and tilmicosin were the next most active compounds, with MICs of less than or equal to 4 microgram/ml. The MICs of aminoglycosides were generally 32 microgram/ml. Both lincomycin and tylosin were relatively inactive against the IS intracellularis strains tested, with MICs of 32 and 64 microgram/ml, respectively. These results indicate that some compounds capable of intracytoplasmic accumulation and blocking bacterial protein synthesis were active against IS intracellularis strains isolated from pigs with proliferative enteropathy. The in vitro cultivation system shows promise as a method for studying the interaction between IS intracellularis and antimicrobial agents and for screening new antibiotics for use in therapy</description><identifier>ISSN: 0095-1137</identifier><identifier>EISSN: 1098-660X</identifier><identifier>DOI: 10.1128/jcm.33.5.1314-1317.1995</identifier><identifier>PMID: 7615747</identifier><identifier>CODEN: JCMIDW</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Animals ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; ANTIMICROBIANOS ; ANTIMICROBIEN ; BACTERIA ; Bacteria - drug effects ; Bacteria - isolation &amp; purification ; Bacterial Infections - drug therapy ; Bacterial Infections - microbiology ; Bacterial Infections - veterinary ; Biological and medical sciences ; CERDO ; Drug Resistance, Microbial ; ENFERMEDADES INTESTINALES ; Enteritis - drug therapy ; Enteritis - microbiology ; Enteritis - veterinary ; Evaluation Studies as Topic ; EXPERIMENTACION IN VITRO ; EXPERIMENTATION IN VITRO ; Ileum - microbiology ; MALADIE INTESTINALE ; Medical sciences ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; PORCIN ; Swine ; Swine Diseases - drug therapy ; Swine Diseases - microbiology</subject><ispartof>Journal of Clinical Microbiology, 1995-05, Vol.33 (5), p.1314-1317</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c570t-8c0b10cb264eb10f3cbb42302dd606adfe684dbc5bb4144dfa526236aa0de4cf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC228152/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC228152/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3188,3189,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3507521$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7615747$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.)</creatorcontrib><creatorcontrib>Mackie, R.A</creatorcontrib><creatorcontrib>Lawson, G.H.K</creatorcontrib><title>Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy</title><title>Journal of Clinical Microbiology</title><addtitle>J Clin Microbiol</addtitle><description>Proliferative enteropathy is caused by the microaerophilic obligate intracellular bacterium ileal symbiont (IS) intracellularis. Treatment of this disease is problematic because of the lack of in vivo or in vitro data on the activities of antimicrobial agents. A new procedure for determining the susceptibility of IS intracellularis was developed by using a tissue culture system which promotes the in vitro multiplication of this organism. Nineteen antimicrobial agents were evaluated in triplicate cultures for their intracellular and extracellular activities against up to three IS intracellularis strains isolated from pigs with proliferative enteropathy. The MIC was defined as the lowest concentration which prevented multiplication of 99% of the IS intracellularis isolates. Penicillin, erythromycin, difioxacin, virginiamycin, and chlortetracycline were the most active compounds tested, all with MICs of less than or equal to 1 microgram/ml. Tiamulin and tilmicosin were the next most active compounds, with MICs of less than or equal to 4 microgram/ml. The MICs of aminoglycosides were generally 32 microgram/ml. Both lincomycin and tylosin were relatively inactive against the IS intracellularis strains tested, with MICs of 32 and 64 microgram/ml, respectively. These results indicate that some compounds capable of intracytoplasmic accumulation and blocking bacterial protein synthesis were active against IS intracellularis strains isolated from pigs with proliferative enteropathy. The in vitro cultivation system shows promise as a method for studying the interaction between IS intracellularis and antimicrobial agents and for screening new antibiotics for use in therapy</description><subject>Animals</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>ANTIMICROBIANOS</subject><subject>ANTIMICROBIEN</subject><subject>BACTERIA</subject><subject>Bacteria - drug effects</subject><subject>Bacteria - isolation &amp; purification</subject><subject>Bacterial Infections - drug therapy</subject><subject>Bacterial Infections - microbiology</subject><subject>Bacterial Infections - veterinary</subject><subject>Biological and medical sciences</subject><subject>CERDO</subject><subject>Drug Resistance, Microbial</subject><subject>ENFERMEDADES INTESTINALES</subject><subject>Enteritis - drug therapy</subject><subject>Enteritis - microbiology</subject><subject>Enteritis - veterinary</subject><subject>Evaluation Studies as Topic</subject><subject>EXPERIMENTACION IN VITRO</subject><subject>EXPERIMENTATION IN VITRO</subject><subject>Ileum - microbiology</subject><subject>MALADIE INTESTINALE</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>PORCIN</subject><subject>Swine</subject><subject>Swine Diseases - drug therapy</subject><subject>Swine Diseases - microbiology</subject><issn>0095-1137</issn><issn>1098-660X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNqFkV2L1TAQhoso63H1DwhiBfGuNR9N0l54sSx-wYIXuuBdSNPkdJa0qUm6y_n3ppzDwb3yJgkzzzuZmbco3mJUY0zaj3d6qimtWY0pbqp8iBp3HXtS7DDq2opz9PtpsUOoYxXGVDwvXsR4hxBuGsYuigvBMRON2BXL1ZxgAh18D8qVcY3aLAl6cJAOpbclOLPFD1MPfk4lzCkobZxbnQoQS4jeqWSG0gY_lQvsY_kAaSyX4B1YE1SCe1OaOZngF5XGw8vimVUumlen-7K4_fL51_W36ubH1-_XVzeVZgKlqtWox0j3hDcmPyzVfd8QisgwcMTVYA1vm6HXLIfzUINVjHBCuVJoMI229LL4dKy7rP1kBm22xp1cAkwqHKRXIB9nZhjl3t9LQlrMSNZ_OOmD_7OamOQEcRtczcavUQrRICJa_l8Q87zsVmygOIJ52TEGY8_NYCQ3U2U2VVIqmdxM3Q4hN1Oz8s2_s5x1Jxdz_v0pr6JWzgY1a4hnjDIkGMEZe3fERtiPDxCMVHF6_GlmXh8Zq7xU-2yxvP3Z8byUXOAvMV_EHg</recordid><startdate>19950501</startdate><enddate>19950501</enddate><creator>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.)</creator><creator>Mackie, R.A</creator><creator>Lawson, G.H.K</creator><general>American Society for Microbiology</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19950501</creationdate><title>Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy</title><author>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.) ; Mackie, R.A ; Lawson, G.H.K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c570t-8c0b10cb264eb10f3cbb42302dd606adfe684dbc5bb4144dfa526236aa0de4cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Animals</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>ANTIMICROBIANOS</topic><topic>ANTIMICROBIEN</topic><topic>BACTERIA</topic><topic>Bacteria - drug effects</topic><topic>Bacteria - isolation &amp; purification</topic><topic>Bacterial Infections - drug therapy</topic><topic>Bacterial Infections - microbiology</topic><topic>Bacterial Infections - veterinary</topic><topic>Biological and medical sciences</topic><topic>CERDO</topic><topic>Drug Resistance, Microbial</topic><topic>ENFERMEDADES INTESTINALES</topic><topic>Enteritis - drug therapy</topic><topic>Enteritis - microbiology</topic><topic>Enteritis - veterinary</topic><topic>Evaluation Studies as Topic</topic><topic>EXPERIMENTACION IN VITRO</topic><topic>EXPERIMENTATION IN VITRO</topic><topic>Ileum - microbiology</topic><topic>MALADIE INTESTINALE</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>PORCIN</topic><topic>Swine</topic><topic>Swine Diseases - drug therapy</topic><topic>Swine Diseases - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.)</creatorcontrib><creatorcontrib>Mackie, R.A</creatorcontrib><creatorcontrib>Lawson, G.H.K</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of Clinical Microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McOrist, S. (University of Edinburgh, Easter Bush, Midlothan, UK.)</au><au>Mackie, R.A</au><au>Lawson, G.H.K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy</atitle><jtitle>Journal of Clinical Microbiology</jtitle><addtitle>J Clin Microbiol</addtitle><date>1995-05-01</date><risdate>1995</risdate><volume>33</volume><issue>5</issue><spage>1314</spage><epage>1317</epage><pages>1314-1317</pages><issn>0095-1137</issn><eissn>1098-660X</eissn><coden>JCMIDW</coden><abstract>Proliferative enteropathy is caused by the microaerophilic obligate intracellular bacterium ileal symbiont (IS) intracellularis. Treatment of this disease is problematic because of the lack of in vivo or in vitro data on the activities of antimicrobial agents. A new procedure for determining the susceptibility of IS intracellularis was developed by using a tissue culture system which promotes the in vitro multiplication of this organism. Nineteen antimicrobial agents were evaluated in triplicate cultures for their intracellular and extracellular activities against up to three IS intracellularis strains isolated from pigs with proliferative enteropathy. The MIC was defined as the lowest concentration which prevented multiplication of 99% of the IS intracellularis isolates. Penicillin, erythromycin, difioxacin, virginiamycin, and chlortetracycline were the most active compounds tested, all with MICs of less than or equal to 1 microgram/ml. Tiamulin and tilmicosin were the next most active compounds, with MICs of less than or equal to 4 microgram/ml. The MICs of aminoglycosides were generally 32 microgram/ml. Both lincomycin and tylosin were relatively inactive against the IS intracellularis strains tested, with MICs of 32 and 64 microgram/ml, respectively. These results indicate that some compounds capable of intracytoplasmic accumulation and blocking bacterial protein synthesis were active against IS intracellularis strains isolated from pigs with proliferative enteropathy. The in vitro cultivation system shows promise as a method for studying the interaction between IS intracellularis and antimicrobial agents and for screening new antibiotics for use in therapy</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>7615747</pmid><doi>10.1128/jcm.33.5.1314-1317.1995</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0095-1137
ispartof Journal of Clinical Microbiology, 1995-05, Vol.33 (5), p.1314-1317
issn 0095-1137
1098-660X
language eng
recordid cdi_highwire_asm_jcm_33_5_1314
source American Society for Microbiology Journals; PubMed Central
subjects Animals
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
ANTIMICROBIANOS
ANTIMICROBIEN
BACTERIA
Bacteria - drug effects
Bacteria - isolation & purification
Bacterial Infections - drug therapy
Bacterial Infections - microbiology
Bacterial Infections - veterinary
Biological and medical sciences
CERDO
Drug Resistance, Microbial
ENFERMEDADES INTESTINALES
Enteritis - drug therapy
Enteritis - microbiology
Enteritis - veterinary
Evaluation Studies as Topic
EXPERIMENTACION IN VITRO
EXPERIMENTATION IN VITRO
Ileum - microbiology
MALADIE INTESTINALE
Medical sciences
Microbial Sensitivity Tests
Pharmacology. Drug treatments
PORCIN
Swine
Swine Diseases - drug therapy
Swine Diseases - microbiology
title Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T08%3A06%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20susceptibility%20of%20ileal%20symbiont%20intracellularis%20isolated%20from%20pigs%20with%20proliferative%20enteropathy&rft.jtitle=Journal%20of%20Clinical%20Microbiology&rft.au=McOrist,%20S.%20(University%20of%20Edinburgh,%20Easter%20Bush,%20Midlothan,%20UK.)&rft.date=1995-05-01&rft.volume=33&rft.issue=5&rft.spage=1314&rft.epage=1317&rft.pages=1314-1317&rft.issn=0095-1137&rft.eissn=1098-660X&rft.coden=JCMIDW&rft_id=info:doi/10.1128/jcm.33.5.1314-1317.1995&rft_dat=%3Cproquest_highw%3E16761876%3C/proquest_highw%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c570t-8c0b10cb264eb10f3cbb42302dd606adfe684dbc5bb4144dfa526236aa0de4cf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16761876&rft_id=info:pmid/7615747&rfr_iscdi=true